Anteris Technologies Ltd: Anteris Secures Bridging Facility
Anteris Technologies Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Anteris Technologies Ltd: Trading Halt
Anteris Technologies Ltd: Pause in trading
Anteris Technologies Ltd: Anteris and v2vmedtech Announce Concept Lock for VClip
Anteris Technologies Ltd: Change of Director's Interest Notice
Anteris Technologies Ltd: FIH Data Confirms Optimal Valve Positioning with ComASUR
Anteris Technologies Ltd: Update on Pivotal Trial Submission
Anteris Technologies Ltd: Update on DurAVR Valve-in-Valve Experience
Anteris Technologies Ltd: Data Update on First-in-Human Study of DurAVR at NY Valves
Anteris Technologies Ltd: Notice of Annual General Meeting - Withdrawal of Resolution
Anteris Technologies Ltd: First in Human TAVR in TAVR in SAVR using DurAVR
Anteris Technologies Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Anteris Technologies Ltd: Corporate Governance Statement and Appendix 4G
Anteris Technologies Ltd: Notice of AGM Date and Closing of Nominations for Directors
Anteris Technologies Ltd: Trading Halt
Anteris Technologies Ltd: Pause in trading
Anteris Technologies Ltd: Change of Director's Interest Notice
Anteris Technologies Ltd: Updated 30-day DurAVR THV Clinical Data
Anteris Technologies Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
No Data
No Data